Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo

scientific article published on 27 May 2011

Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ANTIVIRAL.2011.05.009
P698PubMed publication ID21641936

P50authorSusanne HeroldQ51023448
Stephan PleschkaQ123614404
P2093author name stringJürgen Lohmeyer
Oliver Planz
Lidija Cakarova
Katrin Hoegner
Ruth Pinto
P433issue1
P921main subjectNF-κBQ411114
P304page(s)45-56
P577publication date2011-05-27
P1433published inAntiviral ResearchQ4775352
P1476titleInhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo
P478volume92

Reverse relations

cites work (P2860)
Q453419602-Pyridinyl-4(3H)-quinazolinone: a scaffold for anti-influenza A virus compounds.
Q52595634Bat lung epithelial cells show greater host species-specific innate resistance than MDCK cells to human and avian influenza viruses.
Q36255049Carnosine markedly ameliorates H9N2 swine influenza virus-induced acute lung injury
Q38051178Cytokine responses in the common cold and otitis media
Q89967193Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions
Q39229980EP4 Receptor-Associated Protein in Macrophages Protects against Bleomycin-Induced Pulmonary Inflammation in Mice.
Q34104767Early activation of MAP kinases by influenza A virus X-31 in murine macrophage cell lines
Q35193700Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A.
Q37117819Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I.
Q94563280Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway
Q41450597FPR2: A Novel Promising Target for the Treatment of Influenza
Q107272360Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection
Q38007145Highlights in antiviral drug research: antivirals at the horizon
Q34785589Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.
Q28541723In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea
Q30353167Influenza A induced cellular signal transduction pathways.
Q39297691Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK.
Q92213134Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways
Q37547432Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival
Q33612279Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices.
Q92571985Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling
Q41196865Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses
Q34413797New treatments for influenza
Q58745484Newcastle Disease Virus V Protein Promotes Viral Replication in HeLa Cells through the Activation of MEK/ERK Signaling
Q38382900Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections.
Q45326286Pterodontic Acid Isolated from Laggera pterodonta Inhibits Viral Replication and Inflammation Induced by Influenza A Virus
Q56967921Redox Biology of Respiratory Viral Infections
Q94547260Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings
Q37014063Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia
Q24632337Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus
Q52671141Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients.
Q38047645Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection
Q36290432The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
Q28071809The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
Q110566468The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
Q46853154The intricate interplay between RNA viruses and NF-κB.
Q38482440Transcriptome profiling of brain edemas caused by influenza infection and lipopolysaccharide treatment
Q42229719Transfection of influenza A virus nuclear export protein induces the expression of tumor necrosis factor alpha.
Q40225256Transmissible gastroenteritis virus infection induces NF-κB activation through RLR-mediated signaling
Q96172107β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling

Search more.